Back
Merrimack Pharmaceuticals Vs. XPEL Industry Stock Comparison
Buy
55
MACK
Merrimack Pharmaceuticals
Last Price:
15.13
Seasonality Move:
-18.87%
Sell
40
XPEL
XPEL
Last Price:
35.1900
Seasonality Move:
47.92%
Buy
55
Merrimack Pharmaceuticals (MACK)
is a Buy
Is Merrimack Pharmaceuticals a Buy, Sell or Hold?
- The current Merrimack Pharmaceuticals [MACK] share price is $15.13. The Score for MACK is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- MACK is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
40
XPEL (XPEL)
is a Sell
Is XPEL a Buy, Sell or Hold?
- The current XPEL [XPEL] share price is $35.1800. The Score for XPEL is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- XPEL is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MACK Stock Price Chart
What is Merrimack Pharmaceuticals's stock price today?
-
The Merrimack Pharmaceuticals share price today is $15.13
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MACK is experiencing slight buying pressure.
MACK Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.1 | Buy |
| Relative Strength Index (14 RSI): | 78.97 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.8 - 15.14) | Buy |
| Bollinger Bands (100): | (13.67 - 15.07) | Buy |
XPEL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -4.14 | Sell |
| Relative Strength Index (14 RSI): | 36.32 | Sell |
| Chaikin Money Flow: | 167127 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (30.6614 - 49.8614) | Sell |
| Bollinger Bands (100): | (42.2306 - 57.6706) | Sell |
MACK Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 15.13 | Buy |
| 20-day SMA: | 15.03 | Buy |
| 50-day SMA: | 14.84 | Buy |
| 200-day SMA: | 13.44 | Buy |
| 8-day EMA: | 15.12 | Buy |
| 20-day EMA: | 15.03 | Buy |
| 50-day EMA: | 14.81 | Buy |
| 200-day EMA: | 13.6 | Buy |
XPEL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 34.25 | Buy |
| 20-day SMA: | 36.7 | Sell |
| 50-day SMA: | 47.55 | Sell |
| 200-day SMA: | 56.47 | Sell |
| 8-day EMA: | 34.59 | Buy |
| 20-day EMA: | 37.75 | Sell |
| 50-day EMA: | 44.11 | Sell |
| 200-day EMA: | 54.42 | Sell |
Merrimack Pharmaceuticals Earnings Growth & MACK Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
XPEL Earnings Growth & XPEL Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.73 per share, and a decrease next year of $0.00 per share.
Merrimack Pharmaceuticals Technical Analysis
| May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | May 21 | May 22 | May 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 10 | 13 | 14 | 15 | 16 | 17 | 20 | 21 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
XPEL Technical Analysis
| May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 13 | 14 | 15 | 16 | 17 | 20 | 21 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||